| Host: |
E. coli |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Human IL-33-No tag protein was developed from e. coli and has a target region of No tag. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation. |
| Immunoreactivity: |
Measured by its binding ability in a functional ELISA. Immobilized Recombinant human IL33 at 10 Mu g/mL (100 Mu L/well) can bind Recombinant human IL1RL1 with a linear range of 37.8-151.4 ng/mL. |
| Gene Symbol: |
IL33 |
| Gene ID: |
90865 |
| Uniprot ID: |
IL33_HUMAN |
| Immunogen Region: |
Ser112-Thr270 |
| Immunogen: |
Recombinant Human IL-33 Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser112-Thr270) of human IL-33 (Accession #NP_001300973.1). |
| Tissue Specificity | Expressed at high level in high endothelial venules found in tonsils, Peyer patches and mesenteric lymph nodes. Almost undetectable in placenta. |
| Post Translational Modifications | The full-length protein can be released from cells and is able to signal via the IL1RL1/ST2 receptor. However, proteolytic processing by CELA1, CSTG/cathepsin G and ELANE/neutrophil elastase produces C-terminal peptides that are more active than the unprocessed full length protein. May also be proteolytically processed by calpains. Proteolytic cleavage mediated by apoptotic caspases including CASP3 and CASP7 results in IL33 inactivation. In vitro proteolytic cleavage by CASP1 was reported but could not be confirmed in vivo suggesting that IL33 is probably not a direct substrate for that caspase. |
| Function | Cytokine that binds to and signals through the IL1RL1/ST2 receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells. Involved in the maturation of Th2 cells inducing the secretion of T-helper type 2-associated cytokines. Also involved in activation of mast cells, basophils, eosinophils and natural killer cells. Acts as an enhancer of polarization of alternatively activated macrophages. Acts as a chemoattractant for Th2 cells, and may function as an 'alarmin', that amplifies immune responses during tissue injury. Induces rapid UCP2-dependent mitochondrial rewiring that attenuates the generation of reactive oxygen species and preserves the integrity of Krebs cycle required for persistent production of itaconate and subsequent GATA3-dependent differentiation of inflammation-resolving alternatively activated macrophages. In quiescent endothelia the uncleaved form is constitutively and abundantly expressed, and acts as a chromatin-associated nuclear factor with transcriptional repressor properties, it may sequester nuclear NF-kappaB/RELA, lowering expression of its targets. This form is rapidely lost upon angiogenic or pro-inflammatory activation. |
| Protein Name | Interleukin-33Il-33Interleukin-1 Family Member 11Il-1f11Nuclear Factor From High Endothelial VenulesNf-Hev Cleaved Into - Interleukin-3395-270 - Interleukin-3399-270 - Interleukin-33109-270 |
| Database Links | Reactome: R-HSA-1257604Reactome: R-HSA-5689880Reactome: R-HSA-6811558Reactome: R-HSA-9014843 |
| Cellular Localisation | NucleusChromosomeCytoplasmCytoplasmic VesicleSecretory VesicleSecretedSecreted And Released In The Extracellular Milieu By Passing Through The Gasdermin-D (Gsdmd) Pore Following Cleavage By Cela1Associates With Heterochromatin And Mitotic ChromosomesThe Secretion Is Dependent On Protein Unfolding And Facilitated By The Cargo Receptor Tmed10It Results In Protein Translocation From The Cytoplasm Into The Ergic (Endoplasmic Reticulum-Golgi Intermediate Compartment) Followed By Vesicle Entry And Secretion |
| Alternative Protein Names | Interleukin-33 proteinIl-33 proteinInterleukin-1 Family Member 11 proteinIl-1f11 proteinNuclear Factor From High Endothelial Venules proteinNf-Hev Cleaved Into - Interleukin-33 protein95-270 - Interleukin-33 protein99-270 - Interleukin-33 protein109-270 proteinIL33 proteinC9orf26 proteinIL1F11 proteinNFHEV protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
